Cargando…

Potent Bile Acid Microbial Metabolites Modulate Clostridium perfringens Virulence

Clostridium perfringens is a versatile pathogen, inducing diseases in the skin, intestine (such as chicken necrotic enteritis (NE)), and other organs. The classical sign of NE is the foul smell gas in the ballooned small intestine. We hypothesized that deoxycholic acid (DCA) reduced NE by inhibiting...

Descripción completa

Detalles Bibliográficos
Autores principales: Alenezi, Tahrir, Fu, Ying, Alrubaye, Bilal, Alanazi, Thamer, Almansour, Ayidh, Wang, Hong, Sun, Xiaolun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610205/
https://www.ncbi.nlm.nih.gov/pubmed/37887718
http://dx.doi.org/10.3390/pathogens12101202
_version_ 1785128197764939776
author Alenezi, Tahrir
Fu, Ying
Alrubaye, Bilal
Alanazi, Thamer
Almansour, Ayidh
Wang, Hong
Sun, Xiaolun
author_facet Alenezi, Tahrir
Fu, Ying
Alrubaye, Bilal
Alanazi, Thamer
Almansour, Ayidh
Wang, Hong
Sun, Xiaolun
author_sort Alenezi, Tahrir
collection PubMed
description Clostridium perfringens is a versatile pathogen, inducing diseases in the skin, intestine (such as chicken necrotic enteritis (NE)), and other organs. The classical sign of NE is the foul smell gas in the ballooned small intestine. We hypothesized that deoxycholic acid (DCA) reduced NE by inhibiting C. perfringens virulence signaling pathways. To evaluate the hypothesis, C. perfringens strains CP1 and wild-type (WT) HN13 and its mutants were cultured with different bile acids, including DCA and isoallolithocholic acid (isoalloLCA). Growth, hydrogen sulfide (H(2)S) production, and virulence gene expression were measured. Notably, isoalloLCA was more potent in reducing growth, H(2)S production, and virulence gene expression in CP1 and WT HN13 compared to DCA, while other bile acids were less potent compared to DCA. Interestingly, there was a slightly different impact between DCA and isoalloLCA on the growth, H(2)S production, and virulence gene expression in the three HN13 mutants, suggesting possibly different signaling pathways modulated by the two bile acids. In conclusion, DCA and isoalloLCA reduced C. perfringens virulence by transcriptionally modulating the pathogen signaling pathways. The findings could be used to design new strategies to prevent and treat C. perfringens-induced diseases.
format Online
Article
Text
id pubmed-10610205
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106102052023-10-28 Potent Bile Acid Microbial Metabolites Modulate Clostridium perfringens Virulence Alenezi, Tahrir Fu, Ying Alrubaye, Bilal Alanazi, Thamer Almansour, Ayidh Wang, Hong Sun, Xiaolun Pathogens Article Clostridium perfringens is a versatile pathogen, inducing diseases in the skin, intestine (such as chicken necrotic enteritis (NE)), and other organs. The classical sign of NE is the foul smell gas in the ballooned small intestine. We hypothesized that deoxycholic acid (DCA) reduced NE by inhibiting C. perfringens virulence signaling pathways. To evaluate the hypothesis, C. perfringens strains CP1 and wild-type (WT) HN13 and its mutants were cultured with different bile acids, including DCA and isoallolithocholic acid (isoalloLCA). Growth, hydrogen sulfide (H(2)S) production, and virulence gene expression were measured. Notably, isoalloLCA was more potent in reducing growth, H(2)S production, and virulence gene expression in CP1 and WT HN13 compared to DCA, while other bile acids were less potent compared to DCA. Interestingly, there was a slightly different impact between DCA and isoalloLCA on the growth, H(2)S production, and virulence gene expression in the three HN13 mutants, suggesting possibly different signaling pathways modulated by the two bile acids. In conclusion, DCA and isoalloLCA reduced C. perfringens virulence by transcriptionally modulating the pathogen signaling pathways. The findings could be used to design new strategies to prevent and treat C. perfringens-induced diseases. MDPI 2023-09-28 /pmc/articles/PMC10610205/ /pubmed/37887718 http://dx.doi.org/10.3390/pathogens12101202 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Alenezi, Tahrir
Fu, Ying
Alrubaye, Bilal
Alanazi, Thamer
Almansour, Ayidh
Wang, Hong
Sun, Xiaolun
Potent Bile Acid Microbial Metabolites Modulate Clostridium perfringens Virulence
title Potent Bile Acid Microbial Metabolites Modulate Clostridium perfringens Virulence
title_full Potent Bile Acid Microbial Metabolites Modulate Clostridium perfringens Virulence
title_fullStr Potent Bile Acid Microbial Metabolites Modulate Clostridium perfringens Virulence
title_full_unstemmed Potent Bile Acid Microbial Metabolites Modulate Clostridium perfringens Virulence
title_short Potent Bile Acid Microbial Metabolites Modulate Clostridium perfringens Virulence
title_sort potent bile acid microbial metabolites modulate clostridium perfringens virulence
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610205/
https://www.ncbi.nlm.nih.gov/pubmed/37887718
http://dx.doi.org/10.3390/pathogens12101202
work_keys_str_mv AT alenezitahrir potentbileacidmicrobialmetabolitesmodulateclostridiumperfringensvirulence
AT fuying potentbileacidmicrobialmetabolitesmodulateclostridiumperfringensvirulence
AT alrubayebilal potentbileacidmicrobialmetabolitesmodulateclostridiumperfringensvirulence
AT alanazithamer potentbileacidmicrobialmetabolitesmodulateclostridiumperfringensvirulence
AT almansourayidh potentbileacidmicrobialmetabolitesmodulateclostridiumperfringensvirulence
AT wanghong potentbileacidmicrobialmetabolitesmodulateclostridiumperfringensvirulence
AT sunxiaolun potentbileacidmicrobialmetabolitesmodulateclostridiumperfringensvirulence